GlassScriptPhysician profile
Hannah R Graham
NPI 1578066973
$2,477.95
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $798 · 2022: $731 · 2023: $864 · 2024: $84.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $399.65 | 2021-2023 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $392.50 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.37 | 2021-2023 | Spiriva Respimat, Stiolto Respimat, Jardiance |
| Sanofi-Aventis U.S. LLC | $177.59 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $151.57 | 2021-2024 | Farxiga, Tagrisso |
| Preventric Diagnostics, INC. | $150.50 | 2022 | |
| Glaxosmithkline, LLC. | $118.91 | 2021-2023 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $108.03 | 2021-2023 | Xarelto |
| Pfizer INC. | $102.76 | 2021-2023 | |
| Daiichi Sankyo INC. | $68.68 | 2022-2023 | Injectafer |
| Novartis Pharmaceuticals Corporation | $64.16 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.62 | 2022-2023 | |
| Amgen INC. | $44.72 | 2021-2023 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $41.67 | 2021 | |
| Nevro Corp. | $32.90 | 2023 | Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $23.07 | 2024 | Alecensa, Tecentriq, Rozlytrek |
| Xeris Pharmaceuticals, INC. | $23.00 | 2023 | Gvoke Hypopen |
| Mylan Specialty L.P. | $19.43 | 2023 | Yupelri |
| Exact Sciences Corporation | $19.29 | 2023 | Cologuard Collection Kit |
| Hartmann USA, INC. | $19.10 | 2021 | |
| Abbott Laboratories | $17.26 | 2023 | Freestyle Libre 2 |
| Biohaven Pharmaceutical Holding Company LTD. | $16.94 | 2022 | |
| Ironwood Pharmaceuticals, INC | $16.88 | 2023 | Linzess |
| Regeneron Healthcare Solutions, INC. | $15.51 | 2024 | Libtayo |
| Sumitomo Pharma America, INC. | $14.17 | 2023 | Gemtesa |
| Idorsia Pharmaceuticals US INC | $13.51 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.86 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.